Robert E. Davis
- Biological Psychiatry top 0.5%
- Tryptophan and brain disorders 24
-
- Neuroscience and Neuropharmacology Research 18
- Neurotransmitter Receptor Influence on Behavior 13
- Clinical Biochemistry top 1%
- Psychiatry and Mental health top 1%
- Schizophrenia research and treatment 14
- Bipolar Disorder and Treatment 13
- Neurology top 2%
-
- Receptor Mechanisms and Signaling 26
-
- Treatment of Major Depression 14
- Cholinesterase and Neurodegenerative Diseases 12
- Co-authors
- W. Davis ParkerScott W. MillerRussell H. SwerdlowJanice K. ParksJames P. BennettPatricia A. TrimmerJason P. SheehanJeremy B. Tuttle
- Journals
- Bioorganic & Medicinal Chemistry Letters (7 papers)Schizophrenia Research (7 papers)Schizophrenia Bulletin (7 papers)
- Partner nations
- United StatesSwedenGermany
In The Last Decade
Robert E. Davis
125 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Biological Psychiatry 444
- Cellular and Molecular Neuroscience 1.4k
- Clinical Biochemistry 412
- Psychiatry and Mental health 894
- Neurology 702
Countries citing papers authored by Robert E. Davis
This map shows the geographic impact of Robert E. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Davis more than expected).
Fields of papers citing papers by Robert E. Davis
This network shows the impact of papers produced by Robert E. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Davis. The network helps show where Robert E. Davis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert E. Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 16 | |
| 5 | 2023 | 11 | |
| 6 | 2022 | 14 | |
| 7 | 2022 | 8 | |
| 8 | 2021 | 65 | |
| 9 | 2021 | 20 | |
| 10 | 2018 | 58 | |
| 11 | 2016 | 49 | |
| 12 | 2008 | 28 | |
| 13 | 2008 | 5 | |
| 14 | 2007 | 30 | |
| 15 | Regeneration of Hexaploid Plants of Sweet Cherry Dwarf Rootstock ‘Gisela 6’ from in vitro Leaves Treated with Colchicine | 2006 | 1 |
| 16 | 2002 | 414 | |
| 17 | 1999 | 47 | |
| 18 | 1996 | 107 | |
| 19 | Origin and functional consequences of the complex I defect in Parkinson's diseasebreakdown → | 1996 | 526 |
| 20 | 1994 | 9 |
About Robert E. Davis
Robert E. Davis is a scholar working on Biological Psychiatry, Cellular and Molecular Neuroscience, Pharmacology, Psychiatry and Mental health and Clinical Biochemistry, having authored 129 papers that have together received 4.6k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (26 papers), Tryptophan and brain disorders (24 papers), Neuroscience and Neuropharmacology Research (18 papers), Schizophrenia research and treatment (14 papers), Treatment of Major Depression (14 papers), Neurotransmitter Receptor Influence on Behavior (13 papers), Bipolar Disorder and Treatment (13 papers) and Cholinesterase and Neurodegenerative Diseases (12 papers). The work is most often cited by research in Biological Psychiatry (444 citations), Cellular and Molecular Neuroscience (1.4k citations), Clinical Biochemistry (412 citations), Psychiatry and Mental health (894 citations) and Neurology (702 citations). Robert E. Davis has collaborated with scholars based in United States, Sweden and Germany. Frequent co-authors include W. Davis Parker, Scott W. Miller, Russell H. Swerdlow, Janice K. Parks, James P. Bennett, Patricia A. Trimmer, Jason P. Sheehan, Jeremy B. Tuttle, Kimberly E. Vanover and Sharon Mates. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Schizophrenia Research, Schizophrenia Bulletin, European Neuropsychopharmacology and Psychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.